全文获取类型
收费全文 | 159027篇 |
免费 | 10824篇 |
国内免费 | 625篇 |
专业分类
耳鼻咽喉 | 1769篇 |
儿科学 | 3923篇 |
妇产科学 | 2626篇 |
基础医学 | 20974篇 |
口腔科学 | 3392篇 |
临床医学 | 15572篇 |
内科学 | 33662篇 |
皮肤病学 | 3242篇 |
神经病学 | 14610篇 |
特种医学 | 6967篇 |
外国民族医学 | 14篇 |
外科学 | 25343篇 |
综合类 | 1965篇 |
一般理论 | 109篇 |
预防医学 | 11814篇 |
眼科学 | 3306篇 |
药学 | 10179篇 |
中国医学 | 238篇 |
肿瘤学 | 10771篇 |
出版年
2023年 | 886篇 |
2022年 | 1486篇 |
2021年 | 3379篇 |
2020年 | 2082篇 |
2019年 | 3120篇 |
2018年 | 3593篇 |
2017年 | 2802篇 |
2016年 | 3139篇 |
2015年 | 3585篇 |
2014年 | 5093篇 |
2013年 | 6849篇 |
2012年 | 10341篇 |
2011年 | 11007篇 |
2010年 | 6314篇 |
2009年 | 6016篇 |
2008年 | 9750篇 |
2007年 | 10196篇 |
2006年 | 10099篇 |
2005年 | 10148篇 |
2004年 | 9310篇 |
2003年 | 8622篇 |
2002年 | 8274篇 |
2001年 | 2159篇 |
2000年 | 1849篇 |
1999年 | 2139篇 |
1998年 | 1934篇 |
1997年 | 1558篇 |
1996年 | 1339篇 |
1995年 | 1252篇 |
1994年 | 1129篇 |
1993年 | 1023篇 |
1992年 | 1298篇 |
1991年 | 1200篇 |
1990年 | 1044篇 |
1989年 | 981篇 |
1988年 | 919篇 |
1987年 | 892篇 |
1986年 | 898篇 |
1985年 | 869篇 |
1984年 | 933篇 |
1983年 | 800篇 |
1982年 | 969篇 |
1981年 | 863篇 |
1980年 | 728篇 |
1979年 | 658篇 |
1978年 | 653篇 |
1977年 | 539篇 |
1976年 | 519篇 |
1974年 | 519篇 |
1973年 | 454篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
112.
113.
114.
Summary A study of the association between the rate of proliferation of marrow fibroblast-like stromal cells (in vitro) and the rate of endosteal bone mineralization (EsMR) (in vivo) was undertaken in an osteopenic rat model. We report than 200 g male rats treated with cortisone acetate (5 mg/day for 7
days) exhibit decreases in marrow fibroblast colony-forming units (FCFU) and tetracycline-based measurements of EsMR at the
level of the femoral midshaft. In cortisone-treated rats recovering for 1–3 weeks, the FCFU census and EsMR normalized during
the first posttreatment week, remained at control levels after 2–3 weeks, and exhibited a relapse in the third week which
signified only partial recovery. These changes were unrelated to patterns of body weight gain. The data indicate that the
FCFU census can serve to index endosteal osteoblast vigor. 相似文献
115.
Jan E. Zejda Thomas S. Hurst Ernest M. Barber Charles Rhodes James A. Dosman 《American journal of industrial medicine》1993,23(5):743-750
A cross-sectional survey on respiratory health in swine producers showed that 30% of 301 examined men usually used a dust mask when working inside a barn. They did not differ significantly from dust mask nonusers in respect to respiratory symptoms and lung function. This analysis was undertaken to determine whether the respiratory health of dust mask users was associated with reasons why they had started individual respiratory protection. The subjects were recontacted in order to identify those who started using a mask to deliberately prevent symptoms (42 men) and those who started protection because of pre-existing respiratory symptoms (44 men). Not unexpectedly, betweengroup comparisons of respiratory symptoms and lung function suggest that swine producers who wear dust masks for preventive purposes have better respiratory health than those who wear dust masks because of symptoms or those who do not use individual respiratory protection. The individual reasons for starting dust mask usage should be examined among potential determinants of the outcomes of prospective studies which can then provide more valid assessment of the effect of individual respiratory protection. © 1993 Wiley-Liss, Inc. 相似文献
116.
C M Wilson R J Merritt D W Thomas 《JPEN. Journal of parenteral and enteral nutrition》1988,12(1):81-83
An 11-month-old infant with a central venous catheter for total parenteral nutrition for short gut syndrome developed head and neck swelling. A thrombus at the catheter tip occluding the superior vena cava was demonstrated roentgenographically. A 48-hr infusion of urokinase (4400 units/kg/hr) was administered for thrombolysis. The thrombus cleared clinically and roentgenographically without adverse effects. There has been no recurrence of the superior vena cava syndrome. Urokinase infusion is an alternative to immediate catheter removal in selected patients. 相似文献
117.
Poly{acrylamide-co-[2-(acryloyloxy)ethyltrimethylammonium chloride]} (1) , Poly{acrylamide-co-[2-(methacryloyloxy)ethyltrimethylammonium chloride]} (2) and Poly{acrylamide-co-[3-(acryloylamino)propyltrimethylammonium chloride]} (3) with cationic monomeric unit mole fractions of 8, 25, and 50 mol-%, and the corresponding homopolymers were characterized with respect to their molecular dimensions in 1 M sodium chloride solution at 25°C in the molecular weight range from 200000 to 16000000, using light-scattering and viscometric measurements. It was possible to establish correlations between molecular weight, intrinsic viscosity and radius of gyration. Whereas a steady increase in the exponents of the [η] vs. M- and 〈R2G〉0,5 vs. M-relationships can be observed with increasing charge density, there is an initial decrease in the values of the exponents for 2 and 3 , when 8 mol-% of the cationic monomer is inserted into poly-acrylamide. If the charge density is increased further, these values can also be seen to rise steadily. The findings are explained by the different structures in solution, which are formed by the copolymers and homopolymers investigated due to their chemical structure. The radii of gyration were calculated from the intrinsic viscosities with the aid of the Flory-Fox equation. However, neither the results obtained with the Flory-Fox constant Φ0= 3,69. 1024 mol?1, nor those with the value of Φ0= 2,10. 1024 mol?1 showed good agreement with the experimentally recorded data. 相似文献
118.
Dr. Thomas C. Hardin Pharm.D. FCCP Dr. Steven C. Butler M.D. Dr. Sabine Ross M.D. Dr. John H. Wakeford Pharm.D. Dr. James H. Jorgensen Ph.D. 《Pharmacotherapy》1994,14(2):147-152
Study Objectives . To evaluate the pharmacodynamic antibacterial activity of ticarcillin-clavulanic acid (T-C) and ampicillin-sulbactam (A-S) combinations against reference bacterial strains in patients with end-stage renal disease maintained on long-term hemodialysis. Design . Randomized, crossover, controlled study. Setting . National Institutes of Health-funded general clinical research unit in a Veterans Administration Medical Center. Patients . Nine adult men with end-stage renal disease maintained on long-term hemodialysis. Two subjects did not complete the study due to problems of vascular access, and another withdrew for personal reasons. Interventions . On a nondialysis day, each subject was randomly administered either T-C 3.1 g or A-S 3 g as a slow intravenous infusion over 30 minutes. Serial blood samples were collected for measurement of antibiotic serum concentrations and determination of serum bactericidal titers. Following a washout period, the study was repeated with the alternative antibiotic combination. Measurements and Main Results . The mean observed apparent β-half-life of clavulanic acid was substantially shorter than that for the other three drugs. The bactericidal activity of both A-S and T-C against non-β-lactamase-producing (Nβ-LP) strains of S. aureus and E. coli was consistently high, as indicated by geometric mean SBTs of at least 1:5 at 24 hours. Against β-lactamase-producing (β-LP) S. aureus, the geometric mean SBTs for A-S were at least 1:25 throughout the study period, while the geometric mean SBTs for T-C decreased over 24 hours from 1:29 to 1:6. Against β-LP E. coli, the bactericidal activities for both A-S and T-C were poor, with geometric mean peak SBTs of only 1:6 and 1:3, respectively. The geometric mean SBT for T-C against this E. coli strain had declined to 1:1 at 6 hrs. Conclusion . Increasing the dosing interval for T-C in patients with end-stage renal disease may lead to periods of insufficient clavulanic acid to protect ticarcillin from β-lactamase degradation. 相似文献
119.
Twenty-four patients treated with 150 mg amitriptyline per day for an episode of major depression underwent a standardized heart rate analysis (HRA) before therapy and after 14 days. The battery of cardiovascular reflex tests included the determination of the coefficient of variation (CV) while resting and during deep respiration, a spectral analysis of heart rate, the heart rate response to standing, and the Valsalva manoeuvre. The results of the initial HRA did not differ from a group of 24 normal control subjects matched for age and sex. On day 14 of treatment the patients showed significantly reduced values of heart rate variability in all tests (P<0.0001), probably due to the anticholinergic side effects of amitriptyline. Heart rate increased form 78.1 to 93.6 bpm on average (P<0.0001). Abnormal CV at rest was registered in 96% of the patients; during deep respiration 29% showed abnormal CV results. An abnormal spectral analysis was found in 100% of the cases (low frequency peak: 42%, mid-frequency peak: 100%, high frequency peak: 79%). The heart rate response to standing was abnormal in 75% and the Valsalva test in 33% of the cases. Eighty-eight percent of the patients fulfilled the criteria of a cardiovascular autonomic neuropathy under the conditions of amitriptyline therapy. As yet, the consequences of these changes for the patients have not been sufficiently elucidated. 相似文献
120.
Summary Based upon the hypothesis that dipyridamole would potentiate the cytotoxicity of mitoxantrone and the combination of 5-fluorouracil (5-FU) and leukovorin, we performed a phase I/II trial of the combination of dipyridamole, 5-FU, leukovorin, and mitoxantrone in patients with metastatic breast cancer. The dose of dipyridamole was fixed at 175 mg/m2 by mouth every 6 h (700 mg/m2/day), based upon a previous phase I trial of oral dipyridamole with 5-FU and leukovorin. Dipyridamole therapy began 24 h prior to the first dose of chemotherapy and continued until 24 h after the last dose of chemotherapy for each course of treatment. At the initial dose level, leukovorin 200 mg/m2 was given intravenously immediately prior to 5-FU 375 mg/ m2 intravenously on days 1–5. Mitoxantrone 6 mg/m2 was given as a single dose on day 3. Unacceptable toxicity was observed at this dose level, leading to successive dose decrements rather than dose increments. The maximum tolerated dose was leukovorin 200 mg/m2 days 1–2, 5-FU 375 mg/m2 days 1–2, mitoxantrone 6 mg/m2 on day 2, and dipyridamole 175 mg/m2 every 6 h on days 0–3. Two responses were produced in 15 patients. This regimen is not recommended for further investigation in the treatment of breast cancer. 相似文献